Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: FTSE to track Asian stocks higher

Mon, 02nd Jul 2012 07:30

City sources predict the FTSE 100 will open up six points from Friday's close of 5,571, tracking Asian stocks higher following a round of positive data in both China and Japan. Also boosting sentiment is the progress made at the EU summit held at the end of last week, at which a number of significant steps were taken to allow the single currency region deal with the on-going economic crisis. Marcus Agius, the Chairman of UK banking group Barclays announced his resignation at the weekend, following the revelation last week that the bank had been found guilty of manipulating interbank lending rates. The bank is to pay a £290m fine to UK and US regulators after it was found attempting to control submissions for the London Interbank Offered Rate (LIBOR) and the Euro Interbank Offered Rate (EURIBOR) to benefit the bank's interest rate derivatives traders. Libor and the Euribor are benchmark reference rates that indicate the interest rate that banks charge when lending to each other. Highly acquisitive media giant WPP has agreed to acquire the South Korean media planning and buying agency, Alchemedia, which will be merged into its GroupM Korea subsidiary. Alchemedia, founded in 2004 and based in Seoul, generated revenues of 1.4bn South Korean won (£0.78m) in 2011 and had gross assets of KRW 10bn. The combined company's clients include Audi, GlaxoSmithKline, IBM and Procter & Gamble.Pharmaceuticals giant GlaxoSmithKline (GSK) has revealed positive results from four pivotal phase III studies for its once-daily chronic obstructive pulmonary disease (COPD) treatment, LAMA/LABA. "We are very encouraged by the results of these initial studies for our LAMA/LABA, an important cornerstone of our broad respiratory development portfolio," said Darrell Baker, SVP Respiratory Portfolio Optimisation Leader at GSK.
More News
25 May 2023 10:42

IN BRIEF: Destiny Pharma picks interim CEO as Clark makes quick exit

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Chief Executive Officer Neil Clark steps down immediately "to pursue new challenges". Clark will "support [Destiny] for a limited period to ensure an orderly handover." Non-Executive Director Debra Barker will serve as interim CEO until Destiny appoints a permanent replacement. Barker has held "key roles" at Novartis AG and Polyphor AG, now named Spexis AG. She also has previously worked at Roche Holding AG, Polyneuron Pharmaceuticals AG and GSK PLC.

Read more
15 May 2023 15:23

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

WASHINGTON, May 15 (Reuters) - The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc's challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication.

Read more
15 May 2023 14:37

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

WASHINGTON, May 15 (Reuters) - The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc's challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication.

Read more
12 May 2023 16:53

LONDON MARKET CLOSE: Sterling slides after weak UK GDP print

(Alliance News) - Stocks in London ended the week broadly higher on Friday, with strong performances from blue-chips Beazley and GSK helping to offset weak economic growth data for the UK economy.

Read more
12 May 2023 12:10

LONDON MARKET MIDDAY: FTSE 100 outperforms as Beazley, GSK shine

(Alliance News) - Stock prices in London were mixed at midday on Friday as investors digested a weak GDP reading for the UK, a day after the Bank of England took the country's interest rates up to a 15-year-high.

Read more
12 May 2023 10:08

GSK hails 5-in-1 meningococcal ABCWY vaccine candidate trial data

(Alliance News) - GSK PLC on Friday reported positive preliminary results from a phase 3 trial regarding its 5-in-1 meningococcal ABCWY vaccine candidate.

Read more
12 May 2023 09:03

GSK sells $1 bln discounted stake in spin-off Haleon

GSK sells 240 mln Haleon shares at discount

*

Read more
12 May 2023 08:32

Canadian court dismisses GSK Zantac litigation

(Sharecast News) - A proposed class action against GSK has been dismissed by a court in Canada, the UK drugs giant confirmed on Friday.

Read more
12 May 2023 08:26

TOP NEWS: GSK welcomes legal ruling in Canada; sells Haleon shares

(Alliance News) - GSK PLC on Friday welcomed a legal ruling in Canada that threw out a proposed class action made on behalf of users of a heartburn drug.

Read more
12 May 2023 07:52

GSK sells 2.4% of Haleon stake via placing for £804m

(Sharecast News) - UK pharmaceuticals company GSK said it had sold a 2.5% stake in Haleon at 335p a share, raising £804m.

Read more
12 May 2023 07:50

LONDON BRIEFING: No Apollo offer for THG; GSK trims Haleon stake

(Alliance News) - Stocks in London were called to open higher on Friday, after data showed the UK economy expanded 0.1% over the first three months of the year.

Read more
4 May 2023 07:57

LONDON BRIEFING: Shell sets USD4 billion buyback; Next backs outlook

(Alliance News) - Stocks in London were called to open lower on Thursday, amid a busy day for company earnings and an interest rate decision by the EU's central bank in the afternoon.

Read more
3 May 2023 19:22

IN BRIEF: GSK receives FDA approval for Arexvy in older adults

GSK PLC - Brentford, London-based pharmaceutical firm - Announces the US Food & Drug Administration approves Arexvy, the world's first respiratory syncytial virus vaccine for older adults. States approval enables adults aged 60 years and older to be protected from RSV disease for the first time. Explains the approval is based on data from the positive pivotal AReSVi-006 phase III trial that showed exceptional efficacy in older adults, including those with underlying medical conditions, and in those with severe RSV disease. Plans US launch before the 2023/24 RSV season.

Read more
3 May 2023 17:24

London stocks gain ahead of Fed rate decision; Lloyds drags

Coca Cola HBC AG rises on upbeat forecast

*

Read more
3 May 2023 16:58

LONDON MARKET CLOSE: FTSE 100 in the green ahead of Fed rate decision

(Alliance News) - Stocks in London were higher at the close on Wednesday as investor waited with bated breath for the US Federal Reserve's next interest rate decision.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.